staining were performed. Immunohistochemistry using antiRunx2, anti-Sox9, anti-Collagen II and X, anti-CD31 and CD68 antibodies has been performed. We used also used anti-TNAP (Tissue Nonspecific Alkaline Phosphatase) and ENPP1 (Ectonucleotide Pyrophosphatase/Phosphodiesterase 1) antibodies. Indeed, these two enzymes are essential in the physiological mineralization: extracellular inorganic pyrophosphates are provided by ENPP1 then hydrolyzed by TNAP to promote mineralization. Results Five calcified samples were collected On HE staining, voluminous calcium deposits were encapsulated by a fibrocartilaginous tissue. In one sample, we observed an intra-tendinous osseous metaplasia. This fibrocartilaginous area presented a red coloration (proteoglycan specific) on SO/FG staining but was collagen II negative whereas the fibrocartilage at the tendon attachment was strongly positive. Within this area, cells with round nuclei and pericellular lacunae were observed as previously described (Uhthoff, 1975). These cells expressed Runx2 and Sox9 suggesting a chondrocyte differentiation but only a small number of them expressed type X collagen, hypertrophic chondrocytes-specific marker. These cells also expressed ENPP1 and TNAP. Interestingly, extracellular TNAP deposits were also present at the periphery of the deposits. We identified vessels surrounding the deposits on 4 of the 5 calcified samples. Finally, no CD68 positive cells or TRAP positive cells were detected around the deposits. Conclusions Histological analyses of whole calcified tendon tissues showed a fibrocartilaginous area surrounding the calcium deposits with chondrocyte-like cells expressing ENPP1 and TNAP suggesting their crucial role in the deposition of apatite crystals. Further analyses are necessary to understand the origin of these cells and the regulatory factors involved in their differentiation.
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